Figure 3From: The oncoprotein and stem cell renewal factor BMI1 associates with poor clinical outcome in oesophageal cancer patients undergoing preoperative chemoradiotherapy OS curves and P -values (log-rank test) for comparisons among patients with no residual tumour (Group I), those with BMI1-negative tumours (Group II), patients with no residual tumour and those with BMI1-negative tumours combined (Group I+II), and patients with BMI1-positive tumours (Group III). Back to article page